Reversible Pulmonary Arterial Hypertension Associated with Dasatinib for Chronic Myeloid Leukemia

Reversible Pulmonary Arterial Hypertension Associated with Dasatinib for Chronic Myeloid Leukemia

We describe two cases of pulmonary arterial hypertension (PAH) that occurred under dasatinib treatment and were resolved after dasatinib discontinuation. Two patients with chronic phase chronic myeloid leukemia (CML) were switched to dasatinib therapy because of hematological progress while receivin...

Full description

Bibliographic Details
Main Authors: Hong, Ji Hyung, Lee, Sung-Eun, Choi, Soo Young, Kim, Soo-Hyun, Jang, Eun-Jung, Bang, Ju-Hee, Park, Jin Eok, Jeon, Hye-Rim, Oh, Yun Jeong, Yi, Jeong-Eun, Jung, Hae Ok, Youn, Ho Joong, Kim, Dong-Wook
Format: Online
Language:English
Published: Korean Cancer Association 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614213/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614213/

Similar Items